We are live on ! Find out more
DRNA

Dicerna Pharmaceuticals, Inc.
DRNA

Delisted

DRNA was delisted on the 27th of December, 2021.

Back to rankings

Fund managers haven’t disclosed any holdings of DRNA yet.

DRNA Hedge Fund Activity: Q2 2022 in Review

0 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Dicerna Pharmaceuticals, Inc. (DRNA) for Q2 2022, worth a combined $0 — down 100% from $76K a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of DRNA and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

The largest seller was Close Asset Management, exiting entirely with an estimated $76K sold.

  • 0 institutional investors held Dicerna Pharmaceuticals, Inc. (DRNA) as of Q2 2022, down from 1 in Q1 2022.
  • Funds reported $0 of Dicerna Pharmaceuticals, Inc. stock for Q2 2022, down 100% quarter-over-quarter.
  • 0 funds opened new Dicerna Pharmaceuticals, Inc. positions in Q2 2022 and 1 closed out, a net change of -1 holder.
  • The largest Dicerna Pharmaceuticals, Inc. seller in Q2 2022 was Close Asset Management, an estimated $76K sold.

Based on aggregated 13F filings for Q2 2022.